Fulcrum Equity Partners Closes Oversubscribed Growth Fund IV at $275M

Fulcrum Equity Partners has been an incredible partner to Stratasan since 2019. We’re excited to share that they have closed their fourth and largest fund to date, Fulcrum Growth Fund IV (“Fund IV”), which was oversubscribed with $275 million in committed capital.

In 2019, we at Stratasan completed a $26 million investment round led by Fulcrum Equity Partners!

“We are profoundly grateful for the opportunity to partner with three operationally focused growth equity firms to begin the next chapter in our journey,” said Jason Moore in 2019, Stratasan co-founder and CEO. “We’ve built a customer-first culture, and our entire team is looking forward to providing increased value to our current and future customers through this new investment. As we look to the future, I want to be sure to also thank our current investors and the TNInvestCo program, as they were pivotal in helping us get to where we are today.”

Congratulations to Fulcrum Equity Partners on closing their fourth largest fund to date!

If you’d like to learn more about how Stratasan can help your hospital or healthcare system, book a demo with us. Let us discuss how our software and services can support your specific strategic growth plans and goals. 

Share on facebook
Share on twitter
Share on linkedin